← Back to Clinical Trials
Recruiting NCT06708585

NCT06708585 Information and Progressive Relaxation Exercises

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06708585
Status Recruiting
Phase
Sponsor Nigde Omer Halisdemir University
Condition Caesarean Section
Study Type INTERVENTIONAL
Enrollment 68 participants
Start Date 2024-09-19
Primary Completion 2025-02-20

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
progressive relaxation exercises and training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 68 participants in total. It began in 2024-09-19 with a primary completion date of 2025-02-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was planned to determine the effect of information and progressive relaxation exercises before planned cesarean section on surgical fear, anxiety, postpartum comfort and pain levels.The research will be conducted in experimental design. The research will begin after receiving written permission from Niğde Ömer Halisdemir University Ethics Committee, Niğde Provincial Health Directorate and Ömer Halisdemir Training and Research Hospital. Pregnant women who are between the ages of 18-35, who are on Primigravida, who apply for a planned cesarean section, who have a live single pregnancy, and who are planned for spinal anesthesia will be included in the study. Before starting the research, the study will begin by obtaining institutional permissions and written permission from the pregnant women. Pre-Assessment Form, Personal Information Form, State Anxiety Scale, Surgical Fear Scale, Postpartum Comfort Scale will be used to collect data. The data will be evaluated on a computer using the IBM SPSS Statistics 24 (Statistical Package for the Social Sciences for Windows) package program. Appropriate statistical analyzes will be used to evaluate the data.

Eligibility Criteria

Inclusion Criteria: * Between the ages of 18-35, * Primigravida, * Applied for planned cesarean section, * Live singleton pregnancy, * Spinal anesthesia planned, Exclusion Criteria: * Women who develop postpartum maternal or neonatal complications * Receiving general anesthesia.

Contact & Investigator

Central Contact

BİRNUR YEŞİLDAĞ, Dr

✉ nurumbirnur@gmail.com

📞 05336815923

Principal Investigator

birnur YEŞİLDAĞ, Dr

STUDY DIRECTOR

Ömer Halisdemir University

Frequently Asked Questions

Who can join the NCT06708585 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Caesarean Section. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06708585 currently recruiting?

Yes, NCT06708585 is actively recruiting participants. Contact the research team at nurumbirnur@gmail.com for enrollment information.

Where is the NCT06708585 trial being conducted?

This trial is being conducted at Niğde, Turkey (Türkiye).

Who is sponsoring the NCT06708585 clinical trial?

NCT06708585 is sponsored by Nigde Omer Halisdemir University. The principal investigator is birnur YEŞİLDAĞ, Dr at Ömer Halisdemir University. The trial plans to enroll 68 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology